All In Biotech

Drug Trial Radar · NCT06302491

A Study of Safety and Efficiency of AND017 in Patients With β-thalassemia

A Study of Safety and Efficiency of AND017 in Patients With Transfusion Dependent and Non-transfusion Dependent β-thalassemia

Last checked: Nov 19, 2026Latest source record: Feb 27, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

64

Planned (sponsor's estimate)

Start

May 27, 2024

Primary completion

Dec 2026

Study completion Jul 2027

Sponsor

Lead sponsor
Kind Pharmaceuticals LLCIndustry
Sponsor type
Industry
First posted
Mar 8, 2024

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 18 years, up to 65 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is a phase II, randomized, double-blinded, placebo-controlled study to treat patients with transfusion-dependent and non-transfusion dependent β -thalassemia with AND017 and optimal supportive care, including blood transfusion and iron removal, based on the clinician's judgment and practice.

Conditions

  • β -Thalassemia

Interventions

  • AND017 capsulesDrug

    Administer AND017 capsules once per day (QD)

  • AND017 PlaceboDrug

    Administer AND017 matching placebo capsules once per day (QD)

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Evaluate the safety and tolerability of different oral doses of AND017 in the treatment of β-thalassemia subjectsTime frame: From baseline to Week 24 or End of Treatment if discontinue early

Locations

5 sites in 1 country. Site status is shown where the registry gives one.

  • Nanfang Hospital Southern Medical University

    Guangzhou, Guangdong, China · Not yet recruiting

  • Maoming People's Hospital

    Maoming, Guangdong, China · Recruiting

  • Liuzhou People's Hospital

    Liuzhou, Guangxi, China · Recruiting

  • Guangxi Medical University No.1 Affiliated Hospital

    Nanning, Guangxi, China · Recruiting

  • Hainan General Hospital

    Haikou, Hainan, China · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.